Register Login
Register to leave comments
  • News bot Oct. 22, 2025, 1:04 p.m.

    📋 Jazz Pharmaceuticals plc (JAZZ) - Clinical Trial Update

    Filing Date: 2025-10-22

    Accepted: 2025-10-22 09:01:49

    Event Type: Clinical Trial Update

    Event Details:

    Jazz Pharmaceuticals plc (JAZZ) Announces Clinical Trial Update Jazz Pharmaceuticals plc (JAZZ) provided an update on its clinical development programs. Clinical Development Highlights:
    • Collaboration: Ireland D04 E5W7
    • Updated Timeline: October 21, 2025, 2025-10-21 2025-10-21
      • anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that the Settlement Agreement may not have the expected impact or may require more activity or expense than expected, the risk that the Company may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Settlement Agreement, and other risks. These and other risks and uncertainties relating to the Company and its business can be found under the caption “Risk Factors” and elsewhere in the Company’s Securities and Exchange Commission filings and reports, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2024

    🔬 Clinical Development Pipeline (Jazz Pharmaceuticals plc):

    Product Type Development Stage Therapeutic Area Source
    a benzodiazepine drug DRUG Phase PHASE3 Anxiety Disorder ClinicalTrials.gov
    Epidiolex DRUG Preclinical Maternal Complications ClinicalTrials.gov
    Cannabidiol Oral Solution [Epidiolex] DRUG Phase PHASE4 Tuberous Sclerosis Complex Associated Neuropsychiatric Disease ClinicalTrials.gov
    Allogeneic Hematopoietic Stem Cell Transplantation PROCEDURE Phase PHASE2 Myeloid Neoplasm ClinicalTrials.gov
    MHA DRUG Phase PHASE2 Myeloid Neoplasm ClinicalTrials.gov
    CPX-351 DRUG Phase PHASE2 Myeloid Neoplasm ClinicalTrials.gov
    Evorpacept DRUG Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    Zanidatamab DRUG Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    Glasdegib DRUG Phase PHASE2 Acute Myelogenous Leukemia (AML) Due to Therapy ClinicalTrials.gov
    Vyxeos liposomal DRUG Preclinical Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Capecitabine DRUG Phase PHASE3 Metastatic HER2-positive Breast Cancer ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE3 Metastatic HER2-positive Breast Cancer ClinicalTrials.gov
    Vinorelbine DRUG Phase PHASE3 Metastatic HER2-positive Breast Cancer ClinicalTrials.gov
    Eribulin DRUG Phase PHASE3 Metastatic HER2-positive Breast Cancer ClinicalTrials.gov
    Trastuzumab DRUG Phase PHASE3 Metastatic HER2-positive Breast Cancer ClinicalTrials.gov
    Pertuzumab DRUG Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Cannabidiol DRUG Phase PHASE4 Lennox Gastaut Syndrome ClinicalTrials.gov
    Epidiolex 100 mg/mL Oral Solution DRUG Preclinical Lennox Gastaut Syndrome ClinicalTrials.gov
    5-Fluorouracil DRUG Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    Oxaliplatin DRUG Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    Tislelizumab DRUG Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    Vyxeos DRUG Phase PHASE1 Acute Myeloid Leukemia With FLT3/ITD Mutation ClinicalTrials.gov
    Gilteritinib DRUG Phase PHASE1 Acute Myeloid Leukemia With FLT3/ITD Mutation ClinicalTrials.gov
    Gemtuzumab Ozogamicin DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Matching Placebo DRUG Phase PHASE1 Narcolepsy ClinicalTrials.gov
    JZP441 DRUG Phase PHASE1 Narcolepsy ClinicalTrials.gov
    Durvalumab DRUG Phase PHASE3 Biliary Tract Cancer ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE3 Biliary Tract Cancer ClinicalTrials.gov
    ZW25 (Zanidatamab) DRUG Phase PHASE2 HER2-amplified Biliary Tract Cancers ClinicalTrials.gov
    Bevacizumab DRUG Phase PHASE2 HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer ClinicalTrials.gov
    Leucovorin DRUG Phase PHASE2 HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer ClinicalTrials.gov
    Fluorouracil DRUG Phase PHASE2 HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer ClinicalTrials.gov
    Matched Placebo DRUG Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov
    Cannabidivarin DRUG Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov
    Caphosol DEVICE Phase PHASE1 Oral Mucositis ClinicalTrials.gov
    sodium oxybate DRUG Phase PHASE4 Sleep ClinicalTrials.gov
    Defibrotide DRUG Phase PHASE2 Hepatic Veno-Occlusive Disease ClinicalTrials.gov
    CPX-351 (Cytarabine:Daunorubicin) Liposome Injection DRUG Phase PHASE1 Hematologic Neoplasms ClinicalTrials.gov
    tetracaine gel DRUG Phase PHASE4 Healthy ClinicalTrials.gov
    Rapydan DRUG Phase PHASE4 Healthy ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Fibromyalgia ClinicalTrials.gov
    Xyrem (sodium oxybate) oral solution DRUG Phase PHASE2 Fibromyalgia ClinicalTrials.gov
    Sodium Oxybate Oral Solution (6 grams) DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Sodium Oxybate & 8 Tablets DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Sodium Oxybate & 6 Tablets DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Xyrem® DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Custodiol DRUG Phase PHASE3 Coronary Artery Stenosis ClinicalTrials.gov
    St Thomas DRUG Phase PHASE3 Coronary Artery Stenosis ClinicalTrials.gov
    Modafinil (Placebo) DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Modafinil at established dose DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Xyrem Placebo DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Xyrem DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Placebo (P) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Modafinil (M) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Zolpidem (Z) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Xyrem (X) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) DRUG Phase PHASE2 Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) ClinicalTrials.gov
    mPEG-r-crisantaspase BIOLOGICAL Phase PHASE1 Hematologic Malignancies ClinicalTrials.gov
    experimental anti-anxiety drug DRUG Phase PHASE3 Anxiety Disorder ClinicalTrials.gov
    Bicarbonate de sodium DRUG Phase PHASE2 Hematologic Disease ClinicalTrials.gov
    Clonazepam DRUG Phase PHASE2 Epilepsy ClinicalTrials.gov
    Erwinia Chrysanthemi asparaginase DRUG Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Thioguanine DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Dexamethasone acetate DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Doxorubicin DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Mercaptopurine DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Cyclophosphamide DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Methotrexate DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Rituximab DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Ofatumumab DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    PEG asparaginase DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Prednisone DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Vincristine DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Daunorubicin DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Cytarabine DRUG Phase PHASE2 Leukemia ClinicalTrials.gov
    Erwinase DRUG Phase PHASE2 Hematologic Malignancy ClinicalTrials.gov
    Fludarabine DRUG Phase PHASE2 Hematologic Malignancy ClinicalTrials.gov
    pegcrisantaspase DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Intensive Salvage Therapy DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Ziconotide DRUG Preclinical Patients With Severe Chronic Pain ClinicalTrials.gov
    7+3 (cytarabine and daunorubicin) DRUG Phase PHASE3 High Risk Acute Myeloid Leukemia ClinicalTrials.gov
    JZP-110 DRUG Phase PHASE3 Obstructive Sleep Apnea ClinicalTrials.gov
    Placebo oral tablet DRUG Phase PHASE3 Obstructive Sleep Apnea ClinicalTrials.gov
    Lurbinectedin DRUG Preclinical Small Cell Lung Cancer ClinicalTrials.gov
    External Beam Radiotherapy RADIATION Phase PHASE2 Metastatic Osteosarcoma ClinicalTrials.gov
    Autologous Stem Cell Infusion OTHER Phase PHASE2 Metastatic Osteosarcoma ClinicalTrials.gov
    Sm-EDTMP DRUG Phase PHASE2 Metastatic Osteosarcoma ClinicalTrials.gov
    ADX-N05 DRUG Phase PHASE2 Narcolepsy ClinicalTrials.gov
    asparaginase Erwinia chrysanthemi DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Track 2 BEHAVIORAL Approved Daytime Sleepiness ClinicalTrials.gov
    Track 1 BEHAVIORAL Approved Daytime Sleepiness ClinicalTrials.gov
    Standard of Care DRUG Phase PHASE2 Graft-versus-host Disease ClinicalTrials.gov
    JZP-258 DRUG Phase PHASE3 Narcolepsy With Cataplexy ClinicalTrials.gov
    CX-8998 DRUG Phase PHASE2 Parkinson's Disease ClinicalTrials.gov
    CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection DRUG Phase PHASE2 Colorectal Neoplasms ClinicalTrials.gov
    Asparaginase Erwinia Chrysanthemi (recombinant) DRUG Preclinical Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Placebo Oral Solution DRUG Phase PHASE3 Idiopathic Hypersomnia ClinicalTrials.gov
    Placebo control DRUG Phase PHASE3 Epilepsy ClinicalTrials.gov
    GWP42003-P DRUG Phase PHASE3 Epilepsy ClinicalTrials.gov
    Control (placebo) DRUG Phase PHASE2 Opiate Addiction ClinicalTrials.gov
    CBD 800 mg DRUG Phase PHASE2 Opiate Addiction ClinicalTrials.gov
    CBD 400 mg DRUG Phase PHASE2 Opiate Addiction ClinicalTrials.gov
    Nabiximols DRUG Phase PHASE2 Post-Traumatic Stress Disorder ClinicalTrials.gov
    GWP42003-P 20 mg/kg/day Dose DRUG Phase PHASE3 Epilepsy ClinicalTrials.gov
    Clobazam DRUG Phase PHASE2 Epilepsy ClinicalTrials.gov
    Best Supportive Care OTHER Phase PHASE3 Veno-occlusive Disease ClinicalTrials.gov
    GWP42003-P 10 mg/kg/day Dose DRUG Phase PHASE2 Epilepsy ClinicalTrials.gov
    GWP42003-P 5 mg/kg/day Dose DRUG Phase PHASE2 Epilepsy ClinicalTrials.gov
    Transition from Xyrem to Xywav DRUG Preclinical Narcolepsy ClinicalTrials.gov
    GWP42006 DRUG Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov
    GWP42003 DRUG Phase PHASE2 Schizophrenia ClinicalTrials.gov
    Sativex® DRUG Phase PHASE3 Pain ClinicalTrials.gov
    GWP42004 DRUG Phase PHASE2 Diabetes Mellitus, Type 2 ClinicalTrials.gov
    GW-1000-02 DRUG Phase PHASE3 Multiple Sclerosis ClinicalTrials.gov
    Liposome-encapsulated Daunorubicin-Cytarabine DRUG Phase PHASE2 Recurrent Acute Myeloid Leukemia ClinicalTrials.gov
    Enasidenib Mesylate DRUG Phase PHASE2 Recurrent Acute Myeloid Leukemia ClinicalTrials.gov
    Thiotepa DRUG Phase PHASE2 Acute Myeloid Leukaemia ClinicalTrials.gov
    Busulphan DRUG Phase PHASE2 Acute Myeloid Leukaemia ClinicalTrials.gov
    Cannabidiol (CBD) DRUG Phase PHASE2 Heroin Abuse ClinicalTrials.gov
    Sativex DRUG Phase PHASE4 Multiple Sclerosis ClinicalTrials.gov
    Cannabidiol (Epidiolex) DRUG Phase PHASE4 Study the Efficacy of Epidiolex for Typical Absence Seizures ClinicalTrials.gov
    Haplo-Cord Stem Cell Transplantation BIOLOGICAL Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Rabbit Anti-Human T-Lymphocyte Globulin DRUG Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Melphalan DRUG Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Placebo (GA-0034) DRUG Phase PHASE3 Pain ClinicalTrials.gov
    GW-2000-02 DRUG Phase PHASE3 Pain ClinicalTrials.gov
    Venetoclax DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    THC Alone DRUG Phase PHASE3 Palliative Care ClinicalTrials.gov
    Sativex and omeprazole DRUG Phase PHASE1 Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 ClinicalTrials.gov
    Sativex and ketoconazole DRUG Phase PHASE1 Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 ClinicalTrials.gov
    Sativex and rifampicin DRUG Phase PHASE1 Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 ClinicalTrials.gov
    Marinol DRUG Phase PHASE1 Evaluation of Abuse Potential of Sativex ClinicalTrials.gov
    Solriamfetol DRUG Phase PHASE4 Binge Eating Disorder ClinicalTrials.gov
    Sativex® and fluconazole concomitantly (Treatment B) DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Sativex® (Treatment A) DRUG Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Placebo spray and moxifloxacin DRUG Phase PHASE1 Effects of Sativex on ECG ClinicalTrials.gov
    Sativex spray and oral moxifloxacin placebo DRUG Phase PHASE1 Effects of Sativex on ECG ClinicalTrials.gov
    Placebo spray and oral moxifloxacin placebo DRUG Phase PHASE1 Effects of Sativex on ECG ClinicalTrials.gov
    CPX-315 DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Cytarabine and Idarubicin DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin DRUG Phase PHASE2 Metastatic Cancer ClinicalTrials.gov
    IV JZP-458 DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    IM JZP-458 DRUG Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    JZP341 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Dummy oromucosal DRUG Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    Tetrahydrocannabinol DRUG Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    Enasidenib DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Midostaurin DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    JZP815 DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Etoposide DRUG Phase PHASE3 Small-Cell Lung Cancer ClinicalTrials.gov
    Atezolizumab DRUG Phase PHASE3 Small-Cell Lung Cancer ClinicalTrials.gov
    JZP150 DRUG Phase PHASE2 Post Traumatic Stress Disorder ClinicalTrials.gov
    Positron Emission Tomography PROCEDURE Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Pegfilgrastim BIOLOGICAL Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Filgrastim BIOLOGICAL Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Computed Tomography PROCEDURE Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Bone Marrow Collection PROCEDURE Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Suvecaltamide DRUG Phase PHASE2 Parkinson Disease ClinicalTrials.gov
    Non-investigational surgery PROCEDURE Phase PHASE1 Locally Advanced Soft Tissue Sarcoma ClinicalTrials.gov
    Radiotherapy RADIATION Phase PHASE1 Locally Advanced Soft Tissue Sarcoma ClinicalTrials.gov
    Zepzelca DRUG Preclinical Extensive-stage Small-cell Lung Cancer ClinicalTrials.gov
    Clofarabine DRUG Phase PHASE1 Relapsed Pediatric AML ClinicalTrials.gov
    Vyxeos 44 MG / 100 MG Liposome Injection DRUG Phase PHASE1 Relapsed Pediatric AML ClinicalTrials.gov
    CBD Oral Solution (eCBD system Target) DRUG Phase PHASE2 Fragile X Syndrome ClinicalTrials.gov
    Ramucirumab DRUG Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Tucatinib DRUG Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    Research bone marrow aspirate PROCEDURE Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Research blood draw PROCEDURE Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Research skin biopsy PROCEDURE Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    CBD Oral Solution DRUG Phase PHASE2 Fragile X Syndrome ClinicalTrials.gov
    CD34+ selected allogeneic stem cell transplant from an HLA-compatible donor BIOLOGICAL Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Busulfan DRUG Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Lurbinectedin 4 MG Injection [Zepzelca] DRUG Phase PHASE2 Gastrointestinal Malignancies ClinicalTrials.gov
    JZP385 DRUG Phase PHASE2 Essential Tremor ClinicalTrials.gov
    Fulvestrant DRUG Phase PHASE2 HER2+/HR+ Breast Cancer ClinicalTrials.gov
    Palbociclib DRUG Phase PHASE2 HER2+/HR+ Breast Cancer ClinicalTrials.gov
    JZP898 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    JZP541 DRUG Phase PHASE2 Irritability Associated With Autism Spectrum Disorder ClinicalTrials.gov
    JZP258 DRUG Phase PHASE4 Narcolepsy ClinicalTrials.gov
    Quality-of-Life Assessment OTHER Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Questionnaire Administration OTHER Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Mitoxantrone DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Recombinant Granulocyte Colony-Stimulating Factor BIOLOGICAL Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Cladribine DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    JZP258 (XYWAV) DRUG Phase PHASE4 Idiopathic Hypersomnia ClinicalTrials.gov
    Osimertinib DRUG Phase PHASE1 Small Cell Lung Cancer ( SCLC ) ClinicalTrials.gov
    Nabiximols-matched placebo DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Temozolomide DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Palliative Radiation Therapy RADIATION Phase PHASE1 Extensive Stage Lung Small Cell Carcinoma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Jazz Pharmaceuticals plc
    • CIK: 0001232524
    • Ticker Symbol: JAZZ
    • Period End Date: 2025-10-21
    • Document Type: 8-K

Search

News categories